Beantown Biotech Competitors and Similar CompaniesClear all
Beantown Biotech's competitors and similar companies include Inflazome, Quanterix, Genfit and Labcorp.
 Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. |  Quanterix Quanterix is a platform for single molecule analysis that supports clinical diagnostics, drug development, and life science researches. |  Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs. |  Labcorp Labcorp (also known as Laboratory Corporation of America Holdings) is a life sciences company that provides diagnostic, drug development, and technology-enabled solutions. | ||
Founding Date | Founding Date 2012 | Founding Date 2016 | Founding Date 2007 | Founding Date 1999 | Founding Date 1995 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Natick, US HQ | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB | Locations Billerica, US HQ Baltimore, US Philadelphia, US San Diego, US San Francisco, US Seattle, US | Locations Loos, FR HQ Cambridge, US | |
Employees | Employees 137% decrease | Employees 156% decrease | Employees 24840% increase | Employees 180 | Employees 70,0004% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 506.2 m | Valuation ($) 280.8 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $138.9m (FY, 2025) | Revenue (est.) €65.4m (FY, 2025) | Revenue (est.) $13b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $73.9m (FY, 2025) | Cost of goods €302k (FY, 2025) | Cost of goods $9.4b (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $65m (FY, 2025) | Gross profit €70.8m (FY, 2025) | Gross profit $3.6b (FY, 2024) |
Net income | Net income N/A | Net income N/A | Net income ($107.2m) (FY, 2025) | Net income (€86m) (FY, 2025) | Net income $747.1m (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 17m | Total funding raised $ 96.5m | Total funding raised N/A | Total funding raised $ 350m |
For sources of this data, please see the company profile
View Company Profiles
Inflazome
HQ
Dublin 2, IE
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View companyQuanterix
HQ
Billerica, US
Employees
248↑ 40% increase
Quanterix is a platform for single molecule analysis that supports clinical diagnostics, drug development, and life science researches.
View companyGenfit
HQ
Loos, FR
Employees
180
GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
View companyLabcorp
HQ
Burlington, US
Labcorp (also known as Laboratory Corporation of America Holdings) is a life sciences company that provides diagnostic, drug development, and technology-enabled solutions.
View company